Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Systematic literature review on the economic, humanistic, and societal burden of heart failure in children and adolescents.

Burch M, Nallagangula TK, Lochlainn EN, Severin T, Thakur L, Jaecklin T, George AT, Solar-Yohay S, Rossano JW, Shaddy RE.

Expert Rev Pharmacoecon Outcomes Res. 2019 Feb 12. doi: 10.1080/14737167.2019.1579645. [Epub ahead of print]

PMID:
30747011
2.

[Rosai-Dorfman disease: the review of the literature and the clinical observation of the extranodal form of the disease with the involvement of mucous membranes of the nose and paranasal sinuses].

Edgem SR, Soldatsky YL, Bronin GO, Kul'makov SA, Severin TV.

Vestn Otorinolaringol. 2018;83(6):72-75. doi: 10.17116/otorino20188306172. Russian.

PMID:
30721192
3.

[The observation of two cases of isolated parapharyngeal abscess in a single child].

Bulynko SA, Denisova OA, Soldatsky YL, Severin TV, Cherednichenko AS.

Vestn Otorinolaringol. 2018;83(6):44-45. doi: 10.17116/otorino20188306144. Russian.

PMID:
30721182
4.

Reply to Ensina et al.

Balp MM, Weller K, Carboni V, Chirilov A, Papavassilis C, Severin T, Tian H, Zuberbier T, Maurer M.

Pediatr Allergy Immunol. 2018 Sep;29(6):670-671. doi: 10.1111/pai.12963. No abstract available.

PMID:
30054937
5.

Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients.

Balp MM, Weller K, Carboni V, Chirilov A, Papavassilis C, Severin T, Tian H, Zuberbier T, Maurer M.

Pediatr Allergy Immunol. 2018 Sep;29(6):630-636. doi: 10.1111/pai.12910. Epub 2018 Jul 11.

PMID:
29679413
6.

Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.

Metra M, Davison BA, Gimpelewicz C, Carubelli V, Felker GM, Filippatos G, Greenberg BH, Hua TA, Liu Z, Pang PS, Ponikowski P, Severin TM, Voors AA, Wang Y, Cotter G, Teerlink JR.

Int J Cardiol. 2018 Feb 15;253:91-96. doi: 10.1016/j.ijcard.2017.09.185.

PMID:
29306479
7.

Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents.

Shaddy RE, George AT, Jaecklin T, Lochlainn EN, Thakur L, Agrawal R, Solar-Yohay S, Chen F, Rossano JW, Severin T, Burch M.

Pediatr Cardiol. 2018 Mar;39(3):415-436. doi: 10.1007/s00246-017-1787-2. Epub 2017 Dec 20. Review.

8.

Dementia-specific training for nursing home staff : A systematic literature review.

Riesch J, Meyer L, Lehr B, Severin T.

Z Gerontol Geriatr. 2018 Jul;51(5):523-529. doi: 10.1007/s00391-017-1296-1. Epub 2017 Aug 22. Review.

PMID:
28831611
9.

Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.

Gimpelewicz C, Metra M, Cleland JGF, Szecsödy P, Chang Wun CC, Boer-Martins L, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang P, Ponikowski P, Severin T, Voors AA, Teerlink JR.

Am Heart J. 2017 Aug;190:113-122. doi: 10.1016/j.ahj.2017.05.012. Epub 2017 May 27.

10.

Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua TA, Pang PS, Ponikowski P, Qian M, Severin TA, Voors AA, Teerlink JR.

Clin Res Cardiol. 2017 Nov;106(11):938. doi: 10.1007/s00392-017-1139-5. No abstract available.

PMID:
28752374
11.

Chemostat studies of bacteriophage M13 infected Escherichia coli JM109 for continuous ssDNA production.

Kick B, Behler KL, Severin TS, Weuster-Botz D.

J Biotechnol. 2017 Sep 20;258:92-100. doi: 10.1016/j.jbiotec.2017.06.409. Epub 2017 Jun 20.

PMID:
28645580
12.

Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial.

Pang PS, Teerlink JR, Boer-Martins L, Gimpelewicz C, Davison BA, Wang Y, Voors AA, Severin T, Ponikowski P, Hua TA, Greenberg BH, Filippatos G, Felker GM, Cotter G, Metra M.

Am Heart J. 2017 May;187:62-69. doi: 10.1016/j.ahj.2017.02.024. Epub 2017 Feb 22.

13.

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.

Teerlink JR, Voors AA, Ponikowski P, Pang PS, Greenberg BH, Filippatos G, Felker GM, Davison BA, Cotter G, Gimpelewicz C, Boer-Martins L, Wernsing M, Hua TA, Severin T, Metra M.

Eur J Heart Fail. 2017 Jun;19(6):800-809. doi: 10.1002/ejhf.830. Epub 2017 Apr 28.

14.

Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.

Filippatos GS, de Graeff P, Bax JJ, Borg JJ, Cleland JG, Dargie HJ, Flather M, Ford I, Friede T, Greenberg B, Henon-Goburdhun C, Holcomb R, Horst B, Lekakis J, Mueller-Velten G, Papavassiliou AG, Prasad K, Rosano GM, Severin T, Sherman W, Stough WG, Swedberg K, Tavazzi L, Tousoulis D, Vardas P, Ruschitzka F, Anker SD.

Eur J Heart Fail. 2017 Apr;19(4):449-456. doi: 10.1002/ejhf.761. Epub 2017 Mar 8. Review.

15.

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.

Snowdon VK, Lachlan NJ, Hoy AM, Hadoke PW, Semple SI, Patel D, Mungall W, Kendall TJ, Thomson A, Lennen RJ, Jansen MA, Moran CM, Pellicoro A, Ramachandran P, Shaw I, Aucott RL, Severin T, Saini R, Pak J, Yates D, Dongre N, Duffield JS, Webb DJ, Iredale JP, Hayes PC, Fallowfield JA.

PLoS Med. 2017 Feb 28;14(2):e1002248. doi: 10.1371/journal.pmed.1002248. eCollection 2017 Feb.

16.

Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua TA, Pang PS, Ponikowski P, Qian M, Severin TA, Voors AA, Teerlink JR.

Clin Res Cardiol. 2017 Jun;106(6):444-456. doi: 10.1007/s00392-016-1074-x. Epub 2017 Feb 1. Erratum in: Clin Res Cardiol. 2017 Jul 27;:.

17.

A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.

Demissei BG, Cotter G, Prescott MF, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Severin TM, Wang Y, Qian M, Teerlink JR, Metra M, Davison BA, Voors AA.

Eur J Heart Fail. 2017 Aug;19(8):1001-1010. doi: 10.1002/ejhf.749. Epub 2017 Jan 30.

18.

Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study.

Meyer S, Teerlink JR, Metra M, Ponikowski P, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Hua TA, Severin T, Qian M, Voors AA.

Clin Res Cardiol. 2017 Apr;106(4):280-292. doi: 10.1007/s00392-016-1051-4. Epub 2016 Nov 12.

19.

Dynamics of Heterocapsa sp. and the associated attached and free-living bacteria under the influence of dispersed and undispersed crude oil.

Severin T, Bacosa HP, Sato A, Erdner DL.

Lett Appl Microbiol. 2016 Dec;63(6):419-425. doi: 10.1111/lam.12661. Epub 2016 Nov 3.

PMID:
27562007
20.

Impact of an intense water column mixing (0-1500 m) on prokaryotic diversity and activities during an open-ocean convection event in the NW Mediterranean Sea.

Severin T, Sauret C, Boutrif M, Duhaut T, Kessouri F, Oriol L, Caparros J, Pujo-Pay M, Durrieu de Madron X, Garel M, Tamburini C, Conan P, Ghiglione JF.

Environ Microbiol. 2016 Dec;18(12):4378-4390. doi: 10.1111/1462-2920.13324. Epub 2016 Jun 2.

PMID:
27059603
21.

Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial.

Pang PS, Teerlink JR, Voors AA, Ponikowski P, Greenberg BH, Filippatos G, Felker GM, Davison BA, Cotter G, Kriger J, Prescott MF, Hua TA, Severin T, Metra M.

JACC Heart Fail. 2016 Jul;4(7):591-599. doi: 10.1016/j.jchf.2016.02.009. Epub 2016 Mar 30.

22.

Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF.

Liu LC, Voors AA, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Chen Y, Greenberg BH, Ponikowski P, Pang PS, Prescott MF, Hua TA, Severin TM, Metra M.

Clin Res Cardiol. 2016 Sep;105(9):727-37. doi: 10.1007/s00392-016-0979-8. Epub 2016 Mar 26.

23.

Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study.

Felker GM, Mentz RJ, Teerlink JR, Voors AA, Pang PS, Ponikowski P, Greenberg BH, Filippatos G, Davison BA, Cotter G, Prescott MF, Hua TA, Lopez-Pintado S, Severin T, Metra M.

Eur J Heart Fail. 2015 Dec;17(12):1262-70. doi: 10.1002/ejhf.341. Epub 2015 Sep 3.

24.

Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.

Cotter G, Voors AA, Prescott MF, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Milo O, Hua TA, Qian M, Severin TM, Teerlink JR, Metra M, Davison BA.

Eur J Heart Fail. 2015 Nov;17(11):1133-43. doi: 10.1002/ejhf.331. Epub 2015 Sep 3.

25.

A novel milliliter-scale chemostat system for parallel cultivation of microorganisms in stirred-tank bioreactors.

Schmideder A, Severin TS, Cremer JH, Weuster-Botz D.

J Biotechnol. 2015 Sep 20;210:19-24. doi: 10.1016/j.jbiotec.2015.06.402. Epub 2015 Jun 23.

PMID:
26116137
26.

Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study.

Felker GM, Teerlink JR, Butler J, Hernandez AF, Miller AB, Cotter G, Davison BA, Filippatos G, Greenberg BH, Ponikowski P, Voors AA, Hua TA, Severin TM, Unemori E, Metra M.

J Am Coll Cardiol. 2014 Oct 14;64(15):1591-8. doi: 10.1016/j.jacc.2014.05.071.

27.

Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.

Voors AA, Davison BA, Teerlink JR, Felker GM, Cotter G, Filippatos G, Greenberg BH, Pang PS, Levin B, Hua TA, Severin T, Ponikowski P, Metra M; RELAX-AHF Investigators.

Eur J Heart Fail. 2014 Nov;16(11):1230-40. doi: 10.1002/ejhf.170. Epub 2014 Oct 7.

28.

'Rare biosphere' bacteria as key phenanthrene degraders in coastal seawaters.

Sauret C, Séverin T, Vétion G, Guigue C, Goutx M, Pujo-Pay M, Conan P, Fagervold SK, Ghiglione JF.

Environ Pollut. 2014 Nov;194:246-253. doi: 10.1016/j.envpol.2014.07.024. Epub 2014 Aug 25.

PMID:
25156140
29.

Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study.

van Deursen VM, Edwards C, Cotter G, Davison BA, Damman K, Teerlink JR, Metra M, Felker GM, Ponikowski P, Unemori E, Severin T, Voors AA.

J Card Fail. 2014 Jun;20(6):407-13. doi: 10.1016/j.cardfail.2014.03.003. Epub 2014 Mar 15.

PMID:
24642379
30.

[Foreign bodies (disk batteries) in the nose].

Mazur EM, Soldatskiĭ IL, Ivanenko AM, Denisova OA, Severin TV.

Vestn Otorinolaringol. 2014;(6):64-65. doi: 10.17116/otorino2014664-65. Russian.

PMID:
25734313
31.

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial.

Filippatos G, Teerlink JR, Farmakis D, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua T, Ponikowski P, Severin T, Unemori E, Voors AA, Metra M.

Eur Heart J. 2014 Apr;35(16):1041-50. doi: 10.1093/eurheartj/eht497. Epub 2013 Dec 6.

32.

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF.

Metra M, Ponikowski P, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Hua TA, Severin T, Unemori E, Voors AA, Teerlink JR.

Eur Heart J. 2013 Oct;34(40):3128-36. doi: 10.1093/eurheartj/eht371. Epub 2013 Sep 2.

33.

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.

Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Piña IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ.

Eur J Heart Fail. 2013 Oct;15(10):1082-94. doi: 10.1093/eurjhf/hft095. Epub 2013 Jun 19.

34.

Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.

Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld L, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Prescott MF, Edwards C, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin T, Teerlink JR; RELAX-AHF Investigators.

J Am Coll Cardiol. 2013 Jan 15;61(2):196-206. doi: 10.1016/j.jacc.2012.11.005.

35.

FDI Vision 2020: shaping the future of oral health.

Glick M, Monteiro da Silva O, Seeberger GK, Xu T, Pucca G, Williams DM, Kess S, Eiselé JL, Séverin T.

Int Dent J. 2012 Dec;62(6):278-91. doi: 10.1111/idj.12009. No abstract available.

PMID:
23252585
36.

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M; RELAXin in Acute Heart Failure (RELAX-AHF) Investigators.

Lancet. 2013 Jan 5;381(9860):29-39. doi: 10.1016/S0140-6736(12)61855-8. Epub 2012 Nov 7.

PMID:
23141816
37.

Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial.

Lacourcière Y, Taddei S, Konis G, Fang H, Severin T, Zhang J.

J Hypertens. 2012 Oct;30(10):2047-55. doi: 10.1097/HJH.0b013e328356b8ea.

PMID:
22828090
38.

Design of the RELAXin in acute heart failure study.

Ponikowski P, Metra M, Teerlink JR, Unemori E, Felker GM, Voors AA, Filippatos G, Greenberg B, Teichman SL, Severin T, Mueller-Velten G, Cotter G, Davison BA.

Am Heart J. 2012 Feb;163(2):149-55.e1. doi: 10.1016/j.ahj.2011.10.009.

PMID:
22305830
39.

Healthcare workers and influenza vaccination: an ERS-ESCMID Web-based survey.

Blasi F, Palange P, Rohde G, Severin T, Cornaglia G, Finch R.

Clin Microbiol Infect. 2011 Aug;17(8):1223-5. doi: 10.1111/j.1469-0691.2011.03501.x. Epub 2011 May 20.

40.

Harmonising spirometry education with HERMES: training a new generation of qualified spirometry practitioners across Europe.

Steenbruggen I, Mitchell S, Severin T, Palange P, Cooper BG; Spirometry HERMES Task Force.

Eur Respir J. 2011 Mar;37(3):479-81. doi: 10.1183/09031936.00187810. No abstract available.

41.

HERMES criteria for accreditation of European Training Centres: overcoming challenges of accreditation.

Loddenkemper R, Séverin T, Mitchell S, Palange P; Adult HERMES Task Force.

Eur Respir J. 2010 Dec;36(6):1239-41. doi: 10.1183/09031936.00152310. No abstract available.

42.

European Curriculum Recommendations for Training in Paediatric Respiratory Medicine: one step further.

Gappa M, Noël JL, Séverin T, Paton JY; Paediatric HERMES Task Force.

Eur Respir J. 2010 Sep;36(3):478-9. doi: 10.1183/09031936.00097410. No abstract available.

43.

[Quality of life after radical cystectomy - an overview and analysis of a contemporary series].

Severin T, Bub P, Jocham D, Kausch I.

Aktuelle Urol. 2010 Jul;41(4):245-51. doi: 10.1055/s-0030-1247394. Epub 2010 Jun 1. Review. German. Erratum in: Aktuelle Urol. 2010 Jul;41(4):251.

PMID:
20517822
44.

Continuing medical education across Europe: the role of EBAP and the ERS in facing the challenges of life-long learning.

Gaga M, Séverin T, Stevenson R.

Eur Respir J. 2010 Apr;35(4):721-2. doi: 10.1183/09031936.00191209. No abstract available.

45.

A Maillard reaction product enhances eNOS activity in human endothelial cells.

Schmitt CA, Heiss EH, Schachner D, Aristei Y, Severin T, Dirsch VM.

Mol Nutr Food Res. 2010 Jul;54(7):1031-8. doi: 10.1002/mnfr.200900330.

PMID:
20112298
46.

Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine.

Gappa M, Paton J, Baraldi E, Bush A, Carlsen KH, de Jongste JC, Eber E, Fauroux B, McKenzie S, Noël JL, Palange P, Pohunek P, Priftis K, Séverin T, Wildhaber JH, Zivkovic Z, Zach M.

Eur Respir J. 2009 Mar;33(3):464-5. doi: 10.1183/09031936.00001209. No abstract available.

47.

Norfuraneol dephosphorylates eNOS at threonine 495 and enhances eNOS activity in human endothelial cells.

Schmitt CA, Heiss EH, Aristei Y, Severin T, Dirsch VM.

Cardiovasc Res. 2009 Mar 1;81(4):750-7. doi: 10.1093/cvr/cvn326. Epub 2008 Nov 26.

PMID:
19036824
48.

European curriculum recommendations for training in adult respiratory medicine: crossing boundaries with HERMES.

Loddenkemper R, Séverin T, Haslam PL.

Eur Respir J. 2008 Sep;32(3):538-40. doi: 10.1183/09031936.00090908. No abstract available.

49.

First description of three patients with multifocal lymphangiomatosis and protein-losing enteropathy following palliation of complex congenital heart disease with total cavo-pulmonary connection.

Glöckler M, Severin T, Arnold R, Greiner P, Schwab KO, Uhl M, Schlensak C, Rössler J, Dittrich S.

Pediatr Cardiol. 2008 Jul;29(4):771-4. doi: 10.1007/s00246-007-9194-8. Epub 2008 Jan 11.

PMID:
18188635
50.

Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia.

Kennedy MP, Omran H, Leigh MW, Dell S, Morgan L, Molina PL, Robinson BV, Minnix SL, Olbrich H, Severin T, Ahrens P, Lange L, Morillas HN, Noone PG, Zariwala MA, Knowles MR.

Circulation. 2007 Jun 5;115(22):2814-21. Epub 2007 May 21.

PMID:
17515466

Supplemental Content

Loading ...
Support Center